Todos os Artigos

1.236 artigos

Heart Muscle Patches Show Early Promise for Restoring Failing Hearts
Longevity & Aging

Heart Muscle Patches Show Early Promise for Restoring Failing Hearts

Engineered cardiac patches called BioVAT improved heart function and quality of life in early-stage heart failure patients.

Comunicado de Imprensa
28 de mai. de 2026 0
Sitting Over 10 Hours Daily Doubles Adverse Pregnancy Outcome Risk
Longevity & Aging

Sitting Over 10 Hours Daily Doubles Adverse Pregnancy Outcome Risk

A JAMA study found pregnant women sitting 10+ hours daily had twice the risk of preeclampsia, gestational diabetes, and preterm birth.

Comunicado de Imprensa
28 de mai. de 2026 0
Stem Cell Heart Patches Restore Pumping Power in Failing Hearts
Longevity & Aging

Stem Cell Heart Patches Restore Pumping Power in Failing Hearts

Engineered heart muscle patches from stem cells thickened weakened heart walls and improved pumping ability in a small human trial.

Comunicado de Imprensa
28 de mai. de 2026 0
How Pig Organs, Bioprinted Tissue and Stem Cells Could End Transplant Waitlists
Regenerative Medicine

How Pig Organs, Bioprinted Tissue and Stem Cells Could End Transplant Waitlists

Xenotransplantation, 3D bioprinting, and stem cell therapies are converging to solve the global organ shortage crisis.

Comunicado de Imprensa
28 de mai. de 2026 0
Infrared Heat Treatment May Halt Dry Macular Degeneration Before Vision Loss Begins
Longevity & Aging

Infrared Heat Treatment May Halt Dry Macular Degeneration Before Vision Loss Begins

Aalto University researchers found that gentle near-infrared heat can trigger eye cells' natural repair systems, potentially stopping dry AMD early.

Comunicado de Imprensa
28 de mai. de 2026 0
Brain Scans Reveal Long COVID Symptoms Tied to Emotion Centers Not Inflammation
Longevity & Aging

Brain Scans Reveal Long COVID Symptoms Tied to Emotion Centers Not Inflammation

New PET imaging finds no widespread brain inflammation in long COVID patients — pointing instead to heightened activity in stress and emotion regions.

Comunicado de Imprensa
28 de mai. de 2026 0
Scientists Block Brain Protein That Drives Parkinson's Disease Spread
Longevity & Aging

Scientists Block Brain Protein That Drives Parkinson's Disease Spread

UPenn researchers found that blocking GPNMB antibodies halted Parkinson's cell-to-cell spread in lab experiments, opening a path to disease-slowing treatments.

Comunicado de Imprensa
28 de mai. de 2026 0
Perimenopause Doubles Heart Disease Risk Before Menopause Even Begins
Longevity & Aging

Perimenopause Doubles Heart Disease Risk Before Menopause Even Begins

New research shows cardiovascular health drops sharply during perimenopause, making it a critical window for early intervention.

Comunicado de Imprensa
28 de mai. de 2026 0
Smart Ring Blood Pressure Monitor Earns Place in Official Hypertension Guidelines
Longevity & Aging

Smart Ring Blood Pressure Monitor Earns Place in Official Hypertension Guidelines

South Korea's hypertension guidelines now recommend cuffless ring monitors, marking a milestone for wearable BP tracking in clinical practice.

Comunicado de Imprensa
28 de mai. de 2026 0
Multiple Biotechs Close In on Treatments for Muscle-Wasting Diseases
Longevity & Aging

Multiple Biotechs Close In on Treatments for Muscle-Wasting Diseases

Gene therapies and exon-skipping drugs for Duchenne and myotonic dystrophy are nearing FDA submission, with launches potentially by 2027.

Comunicado de Imprensa
28 de mai. de 2026 0
Alzheimer's Vaccine ALZ-101 Clears Phase 1 Safety Bar and Heads to Global Phase 2
Longevity & Aging

Alzheimer's Vaccine ALZ-101 Clears Phase 1 Safety Bar and Heads to Global Phase 2

Alzinova's ALZ-101 vaccine showed no dangerous brain swelling and triggered lasting antibody responses, clearing the path to a global Phase 2 trial.

Comunicado de Imprensa
28 de mai. de 2026 0
Single-Dose Epigenetic Shot Cuts LDL Cholesterol for 18 Months in Primate Trials
Longevity & Aging

Single-Dose Epigenetic Shot Cuts LDL Cholesterol for 18 Months in Primate Trials

Scribe Therapeutics launches first human trial of STX-1150, an epigenetic therapy silencing PCSK9 to slash LDL without permanently altering DNA.

Comunicado de Imprensa
28 de mai. de 2026 0
AnteriorPágina 31 de 103Próximo